ABBV

AbbVie Inc. (ABBV)

Last Price$202.10.6%
Market Cap$356.7B
LTM Free Cash Flow margin
31.7%
5Y avg
38.2%
Drug Manufacturers - General industry median
20.3%
Stock quality & Intrinsic value
6/10
0.2% undervalued

AbbVie Inc. Free Cash Flow margin

Annual
Quarterly
LTM
Industry median
Company stand-alone
ABBV
Healthcare
Crunching data... Almost there!
Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Free Cash Flow margin
35.6%
29.0%
33.8%
32.7%
30.7%
14.7%
30.6%
25.6%
33.4%
39.0%
38.4%
36.7%
39.1%
41.8%
40.6%
ABBV
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for ABBV and see if it's the right time to invest.
Dive in

AbbVie Inc. (ABBV) Free Cash Flow margin comparison analysis

Crunching data... Almost there!

ABBV key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is AbbVie Inc.'s Free Cash Flow margin?

As of today, Microsoft Corp's last 12-month Free Cash Flow margin is 31.7%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Free Cash Flow margin for AbbVie Inc. have been 38.4% over the past three years, and 40.1% over the past five years.

2) Is AbbVie Inc.'s Free Cash Flow margin Good?

As of today, AbbVie Inc.'s Free Cash Flow margin is 31.7%, which is higher than industry median of 20.3%. It indicates that AbbVie Inc.'s Free Cash Flow margin is Good.

3) How does AbbVie Inc.'s Free Cash Flow margin compare to its peers?

As of today, AbbVie Inc.'s Free Cash Flow margin is 31.7%, which is higher than peer median of 23.7%. The list of peers includes GILD, MRK, AMGN, BMY, NVS, JNJ, AZN, PFE, LLY, SNY.